From Drug Company TeGenero's website:
"TGN1412 is a promising novel approach to addressing the medical need in ... inflammatory diseases, which require long-term therapy without severe side effects."
I think they may have found one side-effect though... quite severe too!
My thoughts go out to those involved - and remember kids, there's no such thing as easy money! Shoetree, you have been warned!
MaFt
Wednesday, March 15, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment